KR970042525A - 아미노 알콜 유도체 및 이의 제조방법 - Google Patents

아미노 알콜 유도체 및 이의 제조방법 Download PDF

Info

Publication number
KR970042525A
KR970042525A KR1019960064982A KR19960064982A KR970042525A KR 970042525 A KR970042525 A KR 970042525A KR 1019960064982 A KR1019960064982 A KR 1019960064982A KR 19960064982 A KR19960064982 A KR 19960064982A KR 970042525 A KR970042525 A KR 970042525A
Authority
KR
South Korea
Prior art keywords
group
formula
alkyl
hydroxyl
amino
Prior art date
Application number
KR1019960064982A
Other languages
English (en)
Inventor
마사유키 진보
히데카즈 오야마다
진이치 이노쿠치
Original Assignee
원본미기재
세가가쿠고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 세가가쿠고교 가부시키가이샤 filed Critical 원본미기재
Publication of KR970042525A publication Critical patent/KR970042525A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/18Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with hydroxy groups and at least two amino groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/16Preparation of optical isomers
    • C07C231/18Preparation of optical isomers by stereospecific synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/36Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 (A) 화학식 1의 아미노프로판올 유도체를 화학식 5의 아민과 반응시켜 화학식 2의 아미노 알콜 유도체를 합성하는 단계; (B) 상기 단계 (A)의 화학식 2의 아미노 알콜 유도체로부터 P1을 제거하여 화학식 3의 아미노 알콜 유도체를 합성하는 단계; (C) 상기 단계 (B)의 화학식 3의 아미노 알콜 유도체를 화학식 6 또는 이의 반응성 유도체와 반응시켜 화학식 4의 2-아실아미노 알콜 유도체를 제조하는 단계를 포함하는, 2-아실아미노 알콜 유도체의 제조 방법에 관한 것이다. 화학식 1 : Y-CH2-C*H(NHP1)-C*H(OH)-R1, 화학식 2 : R2-CH2-C*H(NHP1)-C*H(OH)-R1, 화학식 3 : R2-CH2-C*H(NH2)-C*H(OH)-R1, 화학식 4 : R2-CH2-C*H(NHCOR11)-C*H(OH)-R1, 화학식 5 : R2H, 화학식 6 : R11COOH ; 상기식에서, *는 비대칭 탄소 원자이고, P1, R1, R2및 R11은 명세서에서 정의한 바와 같다. 또한 본 발명은 아미노 그룹-보호된 2-아미노프로판을 유도체로부터 여러 단계를 통하여 아실아미노 그룹에 있는 알콜 유도체를 제조하는 방법, 빛 알콜 유도체를 제조하기 위한 방법에서 중간체로써 유용한 신규의 아미노 알콜에 관한 것이다.

Description

아미노 알콜 유도체 및 이의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (12)

  1. (A) 화학식 1의 아미노프로판올 유도체를 화학식 5의 아민과 반응시켜 화학식 2의 아미노 알콜 유도체를 합성하는 단계; (B) 상기 단계 (A)의 화학식 2의 아미노 알콜 유도체로부터 P1을 제거하여 화학식 3의 아미노 알콜 유도체를 합성하는 단계; (C) 상기 단계 (B)의 화학식 3의 아미노 알콜 유도체를 화학식 6 또는 이의 반응성 유도체와 반응시켜 화학식 4의 2-아실아미노 알콜 유도체를 제조하는 단계를 포함하는, 2-아실아미노 알콜 유도체의 제조 방법. 화학식 1 : Y-CH2-C*H(NHP1)-C*H(OH)-R1, 화학식 2 : R2-CH2-C*H(NHP1)-C|*H(OH)-R1, 화학식 3 : R2-CH2-C*H(NH2)-C*H(OH)-R1, 화학식 4 : R2-CH2-C*H(NHCOR11)-C*H(OH)-R1, 화학식 5 : R2H, 화학식 6 : R11COOH ; 상기식에서, *는 비대칭 탄소 원자이고, P1은 알킬그룹 또는 아미노-보호 그룹이며, Y는 이탈 그룹이고, R1은 알킬 그룹, 사이클로알킬 그룹 또는 아릴 그룹이며, R2는 화학식
    으로 나타내고, R3및 R4는 동일하거나 상이하며 각각 수소원자, 저급 알킬 그룹, 저급 알케닐 그룹, 하이드록시-저급-알킬 그룹, 저급 알콕시알킬 그룹, 아미노-저급 -알킬 그룹, 사이클로알킬 그룹, 하이드록시사이클로알킬 그룹, 아르알킬 그룹, 또는 저급 알킬 그룹으로 치환될 수 있는 피페라지노 그룹이며; R5는 수소 원자, 또는 동일하거나 상이하며 하디드록실 그룹, 저급 알킬 그룹, 저급 알콕실 그룹, 하이드록시-저급-알킬 그룹, 카복실 그룹, (저급 알콕실)카보닐 그룹, 아르알킬 그룹, 피페리디노 그룹, 아실옥시 그룹, 아니노 그룹 및 아미노-저급 알킬 그룹으로부터 선택된 하나이상의 치환체이고; R6은 수소 원자, 또는 동일하거나 상이하며 상기 R5에서 정의한 바와 같은 치환체로부터 선택된 하나 이상의 전환체이고; R7은 산소 원자에 의해 불연속될 수 있는 저급 알킬렌 그룹이며; R8및 R9는 동일하거나 상이하며, 각각 수소 원자, 저급 알킬 그룹 또는 하이드록실-저급-알킬 그룹이거나, R8및 R9가 이들이 결합되어 있는 질소 원자와 함께, 저급 알킬 그룹으로 치환될 수 있는 모르폴리노 그룹 또는 피페리디노 그룹이고; m은 2 내지 6의 정수이며; p는 2 또는 3의 정수이고; X는 화학식
    R10은 수소원자, 저급 알킬 그룹, 아실 그룹, (저급 알콕실)카보닐 그룹 또는 피리딜 그룹이고, R11은 하이드록실 그룹으로 치환될 수 있는, 탄소수 3 내지 18의 알킬 또는 알케닐 그룹이다.
  2. 제 1 항에 있어서, 화학식 1 중 R1이 알킬 그룹; 사이클로알킬 그룹; 또는 동일하거나 상이하여 저급 알킬 그룹, 저급 알콕실 그룹, 하이드록실 그룹, 하이드록실-저급-알킬 그룹 및 니트로 그룹으로부터 선택된 1 내지 3 개의 치환체에 의해 치환될 수 있는 페닐 그룹이고; 화학식 1중 P1이 탄소수 2 내지 18의 알킬 그룹, 또는 (i) 니트로 그룹, 할로겐 원자, 저급 알콕실 그룹, (저급 알콕실)페닐아조 그룹 또는 페닐아조 그룹으로 치환될 수 있는 벤질옥시카보닐 그룹 및 (ii) 플루오레닐 그룹 또는 메틸설포닐 그룹으로 치환될 수 있는, 직쇄, 측쇄 또는 사이클릭 알킬 그룹을 함유하는 알콕시카보닐 그룹으로부터 선택된 아미노-보호 그룹인 방법.
  3. 제 1 항에 있어서, 화학식 1중 R1이 페닐 그룹, 디메톡시페닐 그룹 또는 디하이드록시페닐 그룹이고, R2가 모르폴리노 그룹인 방법.
  4. 제 1 항에 있어서, 화학식 1중 R1이 탄소수 6 내지 15의 알킬 그룹, 사이클로 헥실 그룹 또는 페닐 그룹이고, R2가 (저급 알킬) 아미노 그룹, (모르폴리노-저급알킬)아미노 그룹, 하이드록실 그룹으로 치환될 수 있는 사이클로알킬아미노 그룹, 하이드록실 그룹 또는 하이드록실-저급-알킬 그룹으로 치환될 수 있는 피롤리디노그룹, 저급 알킬 그룹으로 치환될 수 있는 피페라지노 그룹, 비스(하이드록실-저급-알킬)아미노 그룹, 또는 하이드록실 그룹 또는 하이드록실-저급-알킬 그룹으로 치환될 수 있는 피페리디노 그룹인 방법.
  5. 화학식 2의 아미노 알콜 유도체. 화학식 2 : R2-CH2-C*H(NHP1)-C|*H(OH)-R1, 상기식에서, *는 비대칭 탄소 원자이고, P1, R1및 R2는 각각 제 1항에서 정의한 바와 같다.
  6. 제 5 항에 있어서, R1이 알킬 그룹; 사이클로알킬 그룹; 또는 동일하거나 상이하여 저급 알킬 그룹, 저급 알콕실 그룹, 하이드록실 그룹, 하이드록실-저급-알킬 그룹 및 니트로 그룹으로부터 선택된 1 내지 3 개의 치환체에 의해 치환될 수 있는 페닐 그룹이고; P1이 탄소수 3 내지 18의 알킬 그룹, 또는 (i) 니트로 그룹, 할로겐 원자, 저급 알콕실 그룹, (저급 알콕실)페닐아조 그룹 또는 페닐아조 그룹으로 치환될 수 있는 벤질옥시카보닐 그룹 및 (ii) 플루오레닐 그룹 또는 메틸설포닐 그룹으로 치환될 수 있는, 직쇄, 측쇄 또는 사이클릭 알킬 그룹을 함유하는 알콕시카보닐 그룹으로부터 선택된 아미노-보호 그룹인 아미노 알콜 유도체.
  7. 제 5 항에 있어서, R1이 탄소수 6 내지 15의 알킬 그룹, 사이클로 헥실 그룹 또는 페닐 그룹이고, P1이 데실 그룹이거나, 벤질옥시카보닐 그룹, t-부톡시카보닐 그룹 및 옥틸옥시카보닐 그룹으로부터 선택된 아미노-보호 그룹이며, R2가 모르폴리노 그룹, (저급 알킬) 아미노 그룹, (모르폴리노-저급알킬)아미노 그룹, 하이드록실 그룹으로 치환될 수 있는 사이클로알킬아미노 그룹, 하이드록실 그룹 또는 하이드록실-저급-알킬 그룹으로 치환될 수 있는 피롤리디노그룹, 저급 알킬 그룹으로 치환될 수 있는 피페라지노 그룹, 비스(하이드록실-저급-알킬)아미노 그룹, 또는 하이드록실 그룹 또는 하이드록실-저급-알킬 그룹으로 치환될 수 있는 피페리디노 그룹인 아미노 알콜 유도체.
  8. 제 5 항에 있어서, R1이 페닐 그룹이고, P1이 벤질옥시카보닐 그룹이며, R2가 모르폴리노 그룹, 피롤리디노그룹, 하이드록시피롤리디노 그룹, 하이드록시피페리디노 그룹, N-메틸피페라지노 그룹, 디에탄올아미노 그룹 또는 하이드록시사이클로헥실아미노 그룹이며, 이의 배위가 (1S,2S)인 아미노 알콜 유도체.
  9. 제 5 항에 있어서, R1이 페닐 그룹이고, P1이 벤질옥시카보닐 그룹이며, R2가 모르폴리노 그룹, 피롤리디노그룹, 피페리디노 그룹, 사이클로헥실아미노 그룹 또는 사이클로펜틸아미노 그룹이고, 이의 배위가 (1R,2R)인 아미노 알콜 유도체.
  10. (A) 화학식 1의 아미노프로판올 유도체를 화학식 5의 아민과 반응시켜 화학식 2의 아미노 알콜 유도체를 수득하는 단계를 포함하는, 제 5항 내지 제 9항중 어느 한 항에 따른 아미노 알콜 유도체의 제조방법. 화학식 1 : Y-CH2-C*H(NHP1)-C*H(OH)-R1, 화학식 2 : R2-CH2-C*H(NHP1)-C|*H(OH)-R1, 화학식 5 : R2H 상기식에서, *는 비대칭 탄소 원자이고, P1은 알킬그룹 또는 아미노-보호 그룹이며, Y는 이탈 그룹이고, R1은 알킬 그룹, 사이클로알킬 그룹 또는 아릴 그룹이며, R2는 제 1항에서 정의한 바와 같다.
  11. 화학식 3의 아미노 알콜 유도체. 화학식 3 : R2-CH2-C*H(NH2)-C|*H(OH)-R1상기식에서, *는 비대칭 탄소 원자이고, R1및 R2는 제 1항에서 정의한 바와 같다.
  12. 제 11 항에 있어서, R1이 탄소수 6 내지 15의 알킬 그룹, 사이클로 헥실 그룹 또는 페닐 그룹이고, R2가 모르폴리노 그룹, (저급 알킬) 아미노 그룹, (모르폴리노-저급알킬)아미노 그룹, 하이드록실 그룹으로 치환될 수 있는 사이클로알킬아미노 그룹, 하이드록실 그룹 또는 하이드록실-저급-알킬 그룹으로 치환될 수 있는 피롤리디노그룹, 저급 알킬 그룹으로 치환될 수 있는 피페라지노 그룹, 비스(하이드록실-저급-알킬)아미노 그룹, 또는 하이드록실 그룹 또는 하이드록실-저급-알킬 그룹으로 치환될 수 있는 피페리디노 그룹인 아미노 알콜 유도체.
KR1019960064982A 1995-12-08 1996-12-07 아미노 알콜 유도체 및 이의 제조방법 KR970042525A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP95-345080 1995-12-08
JP34508095 1995-12-08

Publications (1)

Publication Number Publication Date
KR970042525A true KR970042525A (ko) 1997-07-24

Family

ID=18374152

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960064982A KR970042525A (ko) 1995-12-08 1996-12-07 아미노 알콜 유도체 및 이의 제조방법

Country Status (9)

Country Link
US (2) US5907039A (ko)
EP (1) EP0782992B1 (ko)
KR (1) KR970042525A (ko)
CN (1) CN1164530A (ko)
AT (1) ATE248828T1 (ko)
CA (1) CA2192268C (ko)
DE (1) DE69629789T2 (ko)
HU (1) HUP9603389A3 (ko)
NO (1) NO965193L (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972928A (en) * 1997-05-21 1999-10-26 Johns Hopkins University Methods for treatment of conditions associated with lactosylceramide
EP1384719A1 (en) * 1999-07-09 2004-01-28 The Regents of The University of Michigan Inhibitors of the glucosyl ceramide synthase enzyme useful for the treatment of cancers, sphingolipidosis and microbial infections
US6407064B2 (en) * 1999-12-06 2002-06-18 Seikagaku Corporation Aminoalcohol derivative and medicament comprising the same
PL359411A1 (en) * 2000-07-13 2004-08-23 Sankyo Company, Limited Amino alcohol derivatives
WO2002062777A2 (en) * 2001-01-10 2002-08-15 The Regents Of The University Of Michigan Amino ceramide-like compounds and therapeutic methods of use
ES2395463T3 (es) * 2001-07-16 2013-02-15 Genzyme Corporation Un inhibidor de N-acilesfingosina glucosiltransferasa
AU2002348261A1 (en) 2001-11-26 2003-06-10 Genzyme Corporation Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors
US20060217560A1 (en) * 2002-04-29 2006-09-28 Shayman James A Amino ceramide-like compounds and therapeutic methods of use
US6916802B2 (en) * 2002-04-29 2005-07-12 Genzyme Corporation Amino ceramide-like compounds and therapeutic methods of use
US20090111812A1 (en) * 2004-06-14 2009-04-30 Musc Foundation For Research Development Methods for treating inflammatory disorders
EP1805142A4 (en) * 2004-09-23 2009-06-10 Reddy Us Therapeutics Inc PYRIDINE-BASED COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SAME
US8003617B2 (en) * 2004-11-10 2011-08-23 Genzyme Corporation Methods of treating diabetes mellitus
BRPI0607304A2 (pt) 2005-01-26 2009-08-25 Allergan Inc compostos tendo atividade analgésica e/ou imunoestimulante
PT2032134E (pt) 2006-05-09 2015-10-07 Genzyme Corp Métodos de tratamento da doença do fígado gorduroso
WO2008109610A1 (en) * 2007-03-06 2008-09-12 Allergan, Inc. Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
US9314466B2 (en) 2007-03-06 2016-04-19 Allergan, Inc. Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
US8173683B2 (en) 2007-03-06 2012-05-08 Allergan, Inc. Methods for treating cognitive disorders
US20100190792A1 (en) * 2007-03-06 2010-07-29 Allergan, Inc Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
WO2008109286A1 (en) * 2007-03-06 2008-09-12 Allergan, Inc. Methods for treating cognitive disorders using 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds
EP2594565B1 (en) * 2007-05-31 2018-10-24 Genzyme Corporation 2-acylaminopropanol-type glucosylceramide synthase inhibitors
EP2209473B1 (en) 2007-10-05 2017-11-22 Genzyme Corporation Method of treating polycystic kidney diseases with ceramide derivatives
US8389517B2 (en) 2008-07-28 2013-03-05 Genzyme Corporation Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
MX2011003517A (es) 2008-10-03 2011-05-25 Genzyme Corp Inhibidores de la glucosilceramida sintasa tipo 2-acilaminopropanol.
SI3133070T1 (sl) 2009-11-27 2019-11-29 Genzyme Corp Eliglustat (GENZ 112638) kot inhibitor sintaze glukozilceramida za uporabo v postopku zdravljenja Fabrjyeve ali Gaucherjeve bolezni, kjer postopek obsega prilagajanje individualnega terapevtskega odmerka metabolizmu P-450 pacienta
JP6537500B2 (ja) 2013-09-20 2019-07-03 ビオマリン プハルマセウトイカル インコーポレイテッド 疾患治療用のグルコシルセラミドシンターゼ阻害剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041441A (en) * 1988-04-04 1991-08-20 The Regents Of The University Of Michigan Method of chemotherapy using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol
DE4025330A1 (de) * 1990-08-09 1992-02-13 Basf Ag Lipidderivate und verfahren zu deren herstellung
FR2684102B1 (fr) * 1991-11-21 1994-03-11 Etat Francais Delegue Armement Procede de preparation de polyazidoalcools ainsi que de polyaminoalcools et polyazidothiols derives de ceux-ci.
DE69426331T2 (de) * 1993-08-13 2001-06-21 Seikagaku Kogyo Co Ltd Arzneimittel gegen nervöse erkrankungen
US5763438A (en) * 1994-06-10 1998-06-09 Seikagaku Corporation 2-acylaminopropanol compound and medical composition
BE1008307A3 (fr) 1994-06-16 1996-04-02 Europharmaceuticals Sa Sel de nimesulide hydrosoluble, solution aqueuse le contenant, sa preparation et son utilisation.

Also Published As

Publication number Publication date
HU9603389D0 (en) 1997-01-28
CA2192268A1 (en) 1997-06-09
HUP9603389A3 (en) 2000-03-28
EP0782992A1 (en) 1997-07-09
DE69629789D1 (de) 2003-10-09
US5907039A (en) 1999-05-25
DE69629789T2 (de) 2004-07-15
HUP9603389A2 (hu) 1998-08-28
CA2192268C (en) 2009-05-19
CN1164530A (zh) 1997-11-12
NO965193L (no) 1997-06-09
US6335444B1 (en) 2002-01-01
EP0782992B1 (en) 2003-09-03
ATE248828T1 (de) 2003-09-15
NO965193D0 (no) 1996-12-05

Similar Documents

Publication Publication Date Title
KR970042525A (ko) 아미노 알콜 유도체 및 이의 제조방법
ATE145891T1 (de) Verfahren zur herstellung von alkoxyiminoacetamid-derivaten und ein zwischenproduckt dafür
KR910007926A (ko) 1h-아미다조[4,5-c]퀴놀린의 제조방법
DE69304051D1 (de) Verfahren zur herstellung von intermediaten in der synthese von retroviralen protease inhibitoren
KR840000515A (ko) N-아릴-피페라진알칸아미드의 제조법
ATE143355T1 (de) Pharmakologisch wirksame hydrazinderivate und verfahren zu deren herstellung
DE69419662T2 (de) Verfahren zur Herstellung von Benzyliden-Derivaten
KR910016695A (ko) 4-(아미노메틸) 피페리딘 유도체, 그의 제조방법 및 치료에의 이용
ATE154351T1 (de) 2,3-diphenyl-5-pyrrolyl-furan derivate, verfahren und zwischenprodukte für ihre herstellung und ihre verwendung als entzündungshemmende, antiallergische und blutplättchenaggregationshemmende mittel
ATE214070T1 (de) Galanthaminderivate und verfahren zu deren herstellung
KR840007869A (ko) N-아미노피리디늄 베타인의 신규 유도체 및 그 제조방법과 이를 함유한 약제학적 조성물
KR850003389A (ko) 신규의 벤조일우레아 유도체 및 이들중간물질의 제조방법
RU96123249A (ru) Производные аминоспирта и способы их получения
DE69839732D1 (de) Verfahren zur herstellung von 3,4-dihydroxy-3cyclobuten-1,2-dion
ATE39689T1 (de) Neues verfahren zur herstellung von chromenderivaten.
ATE221892T1 (de) Zusammensetzungen erhältlich durch zugabe von tertiären aminen zu acryloxypropylalkoxysilanen, verfahren zu deren herstellung und deren verwendung
JPS6256472A (ja) 四級アンモニウム塩化合物
KR840006209A (ko) 1,2,3,4-테트라하이드로-1-아미노메틸-4-페닐이소퀴놀린의 제조방법
DE59508739D1 (de) Verfahren zur herstellung von 2-piperazincarbonsäurederivaten
DE60323308D1 (de) Verfahren zur Herstellung von n-alkoxycarbonyl-piperidin Derivaten sowie Zwischenverbindungen dafür
SE8302886D0 (sv) Intermediates for preparing substituted 1-piperazine-carboxamides and carbothioamides and use thereof
KR950017918A (ko) N-알킬-n-아릴 카바모일 클로라이드의 제조방법
KR970010774A (ko) 7-아미노-3-클로로-3-세펨-4-카르복실산의 제조방법
KR940014326A (ko) 신규 에틸리덴디티오카르바즈산 유도체 및 그의 제조방법
TH1360A (th) สารประกอบไบไซคลิค

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid